Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
BMC Infect Dis ; 17(1): 516, 2017 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-28743235

RESUMO

BACKGROUND: When bacteria colony persist within a biofilm, suitable drugs are not yet available for the eradication of biofilm-producing bacteria. The aim of this study is to study the effect of magnetic nano-particles-induced hyperthermia on destroying biofilm and promoting bactericidal effects of antibiotics in the treatment of osteomyelitis. METHODS: Sixty 12-weeks-old male Wistar rats were used. A metallic 18G needle was implanted into the bone marrow cavity of distal femur after the injection of Methicillin-sensitive Staphylococcus aureus (MSSA). All animals were divided into 5 different treatment modalities. The microbiological evaluation, scanning electron microscope examination, radiographic examination and then micro-CT evaluation of peri-implant bone resorption were analyzed. RESULTS: The pathomorphological characteristics of biofilm formation were completed after 40-days induction of osteomyelitis. The inserted implants can be heated upto 75 °C by magnetic heating without any significant thermal damage on the surrounding tissue. We also demonstrated that systemic administration of vancomycin [VC (i.m.)] could not eradicate the bacteria; but, local administration of vancomycin into the femoral canal and the presence of magnetic nanoparticles hyperthermia did enhance the eradication of bacteria in a biofilm-based colony. In these two groups, the percent bone volume (BV/TV: %) was significantly higher than that of the positive control. CONCLUSIONS: For the treatment of chronic osteomyelitis, we developed a new modality to improve antibiotic efficacy; the protection effect of biofilms on bacteria could be destroyed by magnetic nanoparticles-induced hyperthermia and therapeutic effect of systemic antibiotics could be enhanced.


Assuntos
Antibacterianos/farmacologia , Hipertermia Induzida/métodos , Osteomielite/terapia , Infecções Relacionadas à Prótese/terapia , Infecções Estafilocócicas/terapia , Animais , Biofilmes , Hipertermia Induzida/instrumentação , Nanopartículas de Magnetita , Masculino , Staphylococcus aureus Resistente à Meticilina , Osteomielite/microbiologia , Ratos Wistar , Infecções Estafilocócicas/microbiologia , Resultado do Tratamento , Vancomicina/farmacologia
2.
J Biomed Nanotechnol ; 12(1): 103-13, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27301176

RESUMO

Effective cancer therapy relies on delivering the therapeutic agent precisely to the target site to improve the treatment outcome and to minimize side effects. Although surgery, chemotherapy, and radiotherapy are the standard methods commonly used in clinics, hyperthermia has been developed as a new and promising strategy for cancer therapy. In this study, magnetic bioceramic hydroxyapatite (mHAP) nanocrystals have been developed as heat mediator for intracellular hyperthermia. Hyaluronic acid (HA) modified mHAP nanocrystals are synthesized by a wet chemical precipitation process to achieve active targeting. The results demonstrate that the HA targeting moiety conjugated by a poly(ethylene glycol) (PEG) spacer arm is successfully immobilized on the surface of mHAP. The HA-modified mHAP possesses relatively good biocompatibility, an adequate biodegradation rate and superparamagnetic properties. The HA-modified mHAP could be localized and internalized into HA receptor-overexpressed malignant cells (e.g., MDA-MB-231 cell) and used as the heat generating agent for intracellular hyperthermia. The results from this study indicate that biocompatible HA-modified mHAP shows promise as a novel heat mediator and a specific targeting nanoagent for intracellular hyperthermia cancer therapy.


Assuntos
Ácido Hialurônico/química , Hipertermia Induzida/métodos , Nanopartículas de Magnetita/uso terapêutico , Terapia de Alvo Molecular/métodos , Nanocápsulas/administração & dosagem , Neoplasias Experimentais/terapia , Adsorção , Animais , Linhagem Celular Tumoral , Cerâmica/química , Nanopartículas de Magnetita/química , Nanopartículas de Magnetita/ultraestrutura , Camundongos , Nanocápsulas/química , Nanocápsulas/ultraestrutura , Neoplasias Experimentais/química , Neoplasias Experimentais/patologia , Resultado do Tratamento
3.
J Biomater Appl ; 30(10): 1589-600, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26935813

RESUMO

The formation of fibrous tissue is part of the natural healing response following a laminectomy. Severe scar tissue adhesion, known as epidural fibrosis, is a common cause of failed back surgery syndrome. In this study, by combining the advantages of drug treatment with a physical barrier, an ibuprofen-conjugated crosslinkable polygalacturonic acid and hyaluronic acid hydrogel was developed for epidural fibrosis prevention. Conjugation was confirmed and measured by 1D(1)H NMR spectroscopy.In vitroanalysis showed that the ibuprofen-conjugated polygalacturonic acid-hyaluronic acid hydrogel showed low cytotoxicity. In addition, the conjugated ibuprofen decreased prostaglandin E2production of the lipopolysaccharide-induced RAW264.7 cells. Histological data inin vivostudies indicated that the scar tissue adhesion of laminectomized male adult rats was reduced by the application of our ibuprofen-conjugated polygalacturonic acid-hyaluronic acid hydrogel. Its use also reduced the population of giant cells and collagen deposition of scar tissue without inducing extensive cell recruitment. The results of this study therefore suggest that the local delivery of ibuprofenviaa polygalacturonic acid-hyaluronic acid-based hydrogel reduces the possibility of epidural fibrosis.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Cicatriz/prevenção & controle , Espaço Epidural/efeitos dos fármacos , Espaço Epidural/patologia , Ibuprofeno/administração & dosagem , Laminectomia/efeitos adversos , Pectinas/química , Animais , Anti-Inflamatórios não Esteroides/uso terapêutico , Cicatriz/etiologia , Cicatriz/patologia , Portadores de Fármacos/química , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Ibuprofeno/uso terapêutico , Masculino , Camundongos , Complicações Pós-Operatórias/patologia , Complicações Pós-Operatórias/prevenção & controle , Células RAW 264.7 , Ratos , Ratos Sprague-Dawley , Aderências Teciduais/etiologia , Aderências Teciduais/patologia , Aderências Teciduais/prevenção & controle , Cicatrização/efeitos dos fármacos
4.
BMC Complement Altern Med ; 15: 324, 2015 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-26370415

RESUMO

BACKGROUND: Hypoxia could lead to microglia activation and inflammatory mediators' overproduction. These inflammatory molecules could amplify the neuroinflammatory process and exacerbate neuronal injury. The aim of this study is to find out whether harpagoside could reduce hypoxia-induced microglia activation. METHODS: In this study, primary microglia cells harvested from neonatal ICR mice were activated by exposure to hypoxia (1 % O2 for 3 h). Harpagoside had been shown to be no cytotoxicity on microglia cells by MTT assay. The scavenger effect of harpagoside on hypoxia-enhanced microglial cells proliferation, associated inflammatory genes expression (COX-II, IL-1ß and IL-6 genes) and NO synthesis were also examined. RESULTS: Hypoxia enhances active proliferation of microglial cells, while harpagoside can scavenge this effect. We find that harpagoside could scavenge hypoxia-enhanced inflammatory genes expression (COX-2, IL-1ß and IL-6 genes) and NO synthesis of microglial cells. Under 3 h' hypoxic stimulation, the nuclear contents of p65 and hypoxia inducible factor-1α (HIF-1α) significantly increase, while the cytosol IκB-α content decreases; these effects can be reversed by 1 h's pre-incubation of 10(-8) M harpagoside. Harpagoside could decrease IκB-α protein phosphorylation and inhibit p65 protein translocation from the cytosol to the nucleus, thus suppress NF-κB activation and reduce the HIF-1α generation. CONCLUSION: These results suggested that the anti-inflammatory mechanism of harpagoside might be associated with the NF-κB signaling pathway. Harpagoside protect against hypoxia-induced toxicity on microglial cells through HIF-α pathway.


Assuntos
Glicosídeos/farmacologia , Hipóxia/metabolismo , Microglia/efeitos dos fármacos , Extratos Vegetais/farmacologia , Substâncias Protetoras/farmacologia , Piranos/farmacologia , Scrophularia/química , Animais , Expressão Gênica/efeitos dos fármacos , Inflamação/metabolismo , Camundongos , Camundongos Endogâmicos ICR
5.
Theranostics ; 5(6): 643-55, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25825603

RESUMO

Age-related orthopedic disorders and bone defects have become a critical public health issue, and cell-based therapy is potentially a novel solution for issues surrounding bone tissue engineering and regenerative medicine. Long-term cultures of primary bone cells exhibit phenotypic and functional degeneration; therefore, culturing cells or tissues suitable for clinical use remain a challenge. A platform consisting of human osteoblasts (hOBs), calcium-alginate (Ca-Alginate) scaffolds, and a self-made bioreactor system was established for autologous transplantation of human osteoblast cell clusters. The Ca-Alginate scaffold facilitated the growth and differentiation of human bone cell clusters, and the functionally-closed process bioreactor system supplied the soluble nutrients and osteogenic signals required to maintain the cell viability. This system preserved the proliferative ability of cells and cell viability and up-regulated bone-related gene expression and biological apatite crystals formation. The bone-like tissue generated could be extracted by removal of calcium ions via ethylenediaminetetraacetic acid (EDTA) chelation, and exhibited a size suitable for injection. The described strategy could be used in therapeutic application and opens new avenues for surgical interventions to correct skeletal defects.


Assuntos
Alginatos/farmacologia , Osteoblastos/citologia , Engenharia Tecidual/métodos , Alicerces Teciduais/química , Alginatos/química , Reatores Biológicos , Proliferação de Células , Células Cultivadas , Ácido Glucurônico/química , Ácido Glucurônico/farmacologia , Ácidos Hexurônicos/química , Ácidos Hexurônicos/farmacologia , Humanos , Osteoblastos/efeitos dos fármacos , Osteoblastos/fisiologia , Engenharia Tecidual/instrumentação
6.
J Mater Sci Mater Med ; 26(4): 168, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25791456

RESUMO

Hyaluronic acid-based hydrogels can reduce postoperative adhesion. However, the long-term application of hyaluronic acid is limited by tissue mediated enzymatic degradation. To overcome this limitation, we developed a polygalacturonic acid and hyaluronate composite hydrogel by Schiff's base crosslinking reaction. The polygalacturonic acid and hyaluronate composite hydrogels had short gelation time (less than 15 s) and degraded by less than 50 % in the presence of hyaluronidase for 7 days. Cell adhesion and migration assays showed polygalacturonic acid and hyaluronate composite hydrogels prevented fibroblasts from adhesion and infiltration into the hydrogels. Compared to hyaluronate hydrogels and commercial Medishield™ gels, polygalacturonic acid and hyaluronate composite hydrogel was not totally degraded in vivo after 4 weeks. In the rat laminectomy model, polygalacturonic acid and hyaluronate composite hydrogel also had better adhesion grade and smaller mean area of fibrous tissue formation over the saline control and hyaluronate hydrogel groups. Polygalacturonic acid and hyaluronate composite hydrogel is a system that can be easy to use due to its in situ cross-linkable property and potentially promising for adhesion prevention in spine surgeries.


Assuntos
Dura-Máter/efeitos dos fármacos , Dura-Máter/patologia , Ácido Hialurônico/administração & dosagem , Hidrogéis/administração & dosagem , Pectinas/administração & dosagem , Aderências Teciduais/prevenção & controle , Adjuvantes Imunológicos/administração & dosagem , Animais , Força Compressiva , Dureza , Masculino , Ratos , Ratos Sprague-Dawley , Aderências Teciduais/patologia , Resultado do Tratamento
7.
BMC Complement Altern Med ; 15: 1, 2015 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-25617057

RESUMO

BACKGROUND: In osteoarthritis (OA), the imbalance of chondrocytes' anabolic and catabolic factors can induce cartilage destruction. Interleukin-1 beta (IL-1ß) is a potent pro-inflammatory cytokine that is capable of inducing chondrocytes and synovial cells to synthesize MMPs. The hypoxia-inducible factor-2alpha (HIF-2alpha, encoded by Epas1) is the catabolic transcription factor in the osteoarthritic process. The purpose of this study is to validate the effects of ecdysteroids (Ecd) on IL-1ß-induced cartilage catabolism and the possible role of Ecd in treatment or prevention of early OA. METHODS: Chondrocytes and articular cartilage was harvested from newborn ICR mice. Ecd effect on chondrocytes viability was tested and the optimal concentration was determined by MTT assay. The effect of HIF-2α (EPAS1) in cartilage catabolism simulated by IL-1ß (5 ng/ml) was evaluated by articular cartilage explants culture. The effects of Ecd on IL-1ß-induced inflammatory conditions and their related catabolic genes expression were analyzed. RESULTS: Interleukin-1ß (IL-1ß) treatment on primary mouse articular cartilage explants enhanced their Epas1, matrix metalloproteinases (MMP-3, MMP-13) and ADAMTS-5 genes expression and down-regulated collagen type II (Col2a1) gene expression. With the pre-treatment of 10(-8) M Ecd, the catabolic effects of IL-1ß on articular cartilage were scavenged. CONCLUSION: In conclusions, Ecd can reduce the IL-1ß-induced inflammatory effect of the cartilage. Ecd may suppress IL-1ß-induced cartilage catabolism via HIF-2α pathway.


Assuntos
Cartilagem Articular/efeitos dos fármacos , Condrócitos/efeitos dos fármacos , Ecdisterona/farmacologia , Interleucina-1beta/metabolismo , Osteoartrite/metabolismo , Animais , Artrópodes , Fatores de Transcrição Hélice-Alça-Hélice Básicos/metabolismo , Cartilagem/efeitos dos fármacos , Cartilagem/metabolismo , Cartilagem Articular/metabolismo , Células Cultivadas , Condrócitos/metabolismo , Colágeno Tipo II/metabolismo , Citocinas/metabolismo , Regulação para Baixo , Expressão Gênica , Masculino , Metaloproteinase 13 da Matriz/genética , Metaloproteinase 13 da Matriz/metabolismo , Metaloproteinase 3 da Matriz/genética , Metaloproteinase 3 da Matriz/metabolismo , Camundongos Endogâmicos ICR , Osteoartrite/prevenção & controle , Membrana Sinovial/metabolismo , Fatores de Transcrição/metabolismo
8.
Lasers Med Sci ; 30(1): 263-72, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25231827

RESUMO

For decades, low-level laser therapy (LLLT) has widespread applications in tendon-related injuries. Although the therapeutic effect of LLLT could be explained by photostimulation of target tissue and cells, how tenocytes sense photonic energy and convert them into cascades of cellular and molecular events is still not well understood. This study was designed to elucidate the effects of LLLT on cell proliferation and collagen synthesis by examining the associated second messengers including ATP, Ca(2+), and nitric oxide using rat Achilles tenocytes. Moreover, proliferating cell nuclear antigen (PCNA) and transforming growth factor-ß1 (TGF-ß1) related to cell proliferation and matrix metabolism were also studied. The results showed that 904 nm GaAs laser of 1 J/cm(2) could significantly increase the MTT activity and collagen synthesis of tenocytes. Second messengers including ATP and intracellular Ca2+ were increased after laser treatment. Quantitative PCR analysis of tenocytes treated with laser revealed up-regulated expression of PCNA, type I collagen, and TGF-ß1. Besides, laser-induced TGF-ß1 expression was significantly inhibited by extracellular signal-regulated kinase (ERK) specific inhibitor (PD98059). The findings suggested that LLLT stimulated ATP production and increased intracellular calcium concentration. Directly or indirectly via production of TGF-ß1, these second messengers mediated the proliferation of tenocytes and synthesis of collagen.


Assuntos
Tendão do Calcâneo/citologia , Tendão do Calcâneo/metabolismo , Terapia com Luz de Baixa Intensidade/métodos , Sistemas do Segundo Mensageiro , Trifosfato de Adenosina/metabolismo , Animais , Cálcio/metabolismo , Proliferação de Células/efeitos da radiação , Colágeno/metabolismo , Colágeno Tipo I/metabolismo , Inibidores Enzimáticos/química , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Óxido Nítrico/metabolismo , Ratos , Ratos Sprague-Dawley , Traumatismos dos Tendões/terapia , Fator de Crescimento Transformador beta1/metabolismo
9.
Chin Med J (Engl) ; 125(20): 3646-53, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23075718

RESUMO

BACKGROUND: Estrogen deficiency results in loss of bone mass. Phytoestrogens are plant-derived non-steroidal compounds with estrogen-like activity that bind to estrogen receptors. The main aim of this study was to investigate the effect of the phytoestrogen puerarin on adult mouse osteoblasts. METHODS: Osteoblast cells were harvested from 8-month old female imprinting control region (ICR) mice. The effects of puerarin stimulation on the proliferation, differentiation and maturation of osteoblasts were examined. The production of nitric oxide (NO) and the expression of bone morphogenetic protein-2 (BMP-2), SMAD4, mitogen-activated protein kinases (MAPK), core binding factor α1/ runt-related transcription factor 2 (Cbfa1/Runx2), osteoprotegerin (OPG), and receptor activator of NF-κB ligand (RANKL) genes were analyzed. The activation of signal pathways was further confirmed by specific pathway inhibitors. RESULTS: The osteoblast viability reached its maximum at 10(-8) mol/L puerarin. At this concentration, puerarin increases the proliferation and matrix mineralization of osteoblasts and promotes NO synthesis. With 10(-8) mol/L puerarin treatment, BMP-2, SMAD4, Cbfa1/Runx2, and OPG gene expression were up-regulated, while the RANKL gene expression is down-regulated. Concurrent treatment involving the (bone morphogenetic protein) BMP antagonist Noggin or the NOS inhibitor L-NAME diminishes puerarin induced cell proliferation, Alkaline phosphatase (ALP) activity, NO production, as well as the BMP-2, SMAD4, Cbfa1/Runx2, OPG, and RANKL gene expression. CONCLUSIONS: In this in vitro study, we demonstrate that puerarin is a bone anabolic agent that exerts its osteogenic effects through the induction of BMP-2 and NO synthesis, subsequently regulating Cbfa1/Runx2, OPG, and RANKL gene expression. This effect may contribute to its induction of osteoblast proliferation and differentiation, resulting in bone formation.


Assuntos
Proteína Morfogenética Óssea 2/fisiologia , Isoflavonas/farmacologia , Sistema de Sinalização das MAP Quinases/fisiologia , Óxido Nítrico/fisiologia , Osteogênese/efeitos dos fármacos , Fitoestrógenos/farmacologia , Animais , Proteína Morfogenética Óssea 2/genética , Diferenciação Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Feminino , Camundongos , Camundongos Endogâmicos ICR , Osteoblastos/efeitos dos fármacos , Osteoblastos/metabolismo , Ligante RANK/genética
10.
Phytomedicine ; 18(2-3): 176-85, 2011 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-20554188

RESUMO

Icariin has been reported to enhance bone healing and treat osteoporosis. In this study, we examined the detail molecular mechanisms of icariin on lipopolysaccharide (LPS)-induced osteolysis. Our hypothesis is that icariin can inhibit osteoclast differentiation and bone resorption by suppressing MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. After treatment with icariin, the activity of osteoclasts differentiation maker, tatrate resistances acid phosphatease (TRAP), significantly decreased at the concentration of 10(-8)M. Icariin (10(-8)M) reduced the size of LPS-induced osteoclasts formation, and diminished their TRAP and acid phosphatease (ACP) activity without inhibition of cell viability. Icariin also inhibited LPS-induced bone resorption and interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) expression. The gene expression of osteoprotegerin (OPG) was up-regulated, while receptor activator of NF-κB ligand (RANKL) was down-regulated. Icariin also inhibited the synthesis of cyclo-oxygenase type-2 (COX-2) and prostaglandin E(2) (PGE(2)). In addition, icariin had a dominant repression effect on LPS-induced hypoxia inducible factor-1α (HIF-1α) expression of osteoclasts. On osteoclasts, icariin suppresses LPS-mediated activation of the p38 and JNK; while on the osteoblasts, icariin reduced the LPS-induced activation of ERK1/2 and I-kappa-B-alpha (IκBα), but increased the activation of p38. In conclusion, we demonstrated that icariin has an in vitro inhibitory effects on osteoclasts differentiation that can prevent inflammatory bone loss. Icariin inhibited LPS-induced osteoclastogenesis program by suppressing activation of the p38 and JNK pathway.


Assuntos
Reabsorção Óssea/tratamento farmacológico , Dinoprostona/biossíntese , Flavonoides/farmacologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/biossíntese , Mediadores da Inflamação/metabolismo , Osteoclastos/efeitos dos fármacos , Osteoporose/prevenção & controle , Animais , Reabsorção Óssea/metabolismo , Diferenciação Celular/efeitos dos fármacos , Ciclo-Oxigenase 2/metabolismo , Epimedium/química , Feminino , Flavonoides/uso terapêutico , Expressão Gênica/efeitos dos fármacos , Interleucina-6/metabolismo , Lipopolissacarídeos , Camundongos , Camundongos Endogâmicos ICR , Proteínas Quinases Ativadas por Mitógeno/metabolismo , NF-kappa B/metabolismo , Osteoclastos/metabolismo , Osteólise/induzido quimicamente , Osteólise/tratamento farmacológico , Osteoporose/metabolismo , Osteoprotegerina/metabolismo , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ligante RANK/metabolismo , RNA Mensageiro/análise , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo
11.
Nutr Res ; 30(1): 57-65, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20116661

RESUMO

Septic arthritis is an inflammatory arthropathy characterized by degeneration of articular cartilage. Icariin, the main active flavonoid glucoside isolated from Epimedium pubescens, is used as antirheumatics (or antiinflammatory), tonics, and aphrodisiacs in traditional Chinese medicine. In this study, we used lipopolysaccharide (LPS) to simulate the in vitro inflammatory response of chondrocytes during septic arthritis. Our hypothesis is that the icariin can protect chondrocytes from LPS-induced inflammation and extracellular matrix degradation. The inflammation of neonatal mice chondrocytes was induced by LPS and the antiinflammatory effects were examined. The synthesis of nitric oxide was analyzed, whereas the titer of glycosaminoglycan and total collagen were measured and the gene expressions (including inducible nitric oxide synthase [iNOS], matrix metalloproteinase [MMP]-1, MMP-3, and MMP-13) were evaluated. The results showed that the viability of chondrocytes, extracellular matrix synthesis, was significantly decreased, whereas nitric oxide synthesis was significantly increased in the presence of 10(-5) g/mL LPS. Icariin pretreatment can partially reverse these effects. The up-regulated expressions of MMP-1, 3, 13, cyclooxygenase-2 (COX-2), and iNOS genes by LPS treatment were also significantly down-regulated by the pretreatment of icariin to 1.8%, 0.056%, 7.7%, 3.1%, and 5.3% of the LPS-positive control sample, respectively. Our results demonstrate that icariin is a safe anabolic agent of chondrocytes. Icariin may exert its protective effects through inhibition of nitric oxide and MMP synthesis, and may then reduce the extracellular matrix destruction.


Assuntos
Anti-Inflamatórios/uso terapêutico , Artrite Infecciosa/tratamento farmacológico , Condrócitos/efeitos dos fármacos , Epimedium/química , Matriz Extracelular/efeitos dos fármacos , Flavonoides/uso terapêutico , Extratos Vegetais/uso terapêutico , Animais , Anti-Inflamatórios/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Condrócitos/metabolismo , Colágeno/metabolismo , Matriz Extracelular/metabolismo , Flavonoides/farmacologia , Glicosaminoglicanos/metabolismo , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Lipopolissacarídeos , Metaloproteinases da Matriz Secretadas/metabolismo , Camundongos , Óxido Nítrico/biossíntese , Fitoterapia , Extratos Vegetais/farmacologia
12.
Phytomedicine ; 17(6): 414-23, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-19747809

RESUMO

Epimedii herba is one of the most frequently used herbs in formulas prescribed for the treatment of osteoporosis in China. The main active flavonoid glucoside extracted from Epimedium pubescens is Icariin, which has been reported to enhance bone healing and reduce osteoporosis occurrence. However, the detailed molecular mechanisms remain unclear. In this present study, we examine the molecular mechanisms of icariin by using primary osteoblast cell cultures obtained from adult mice. The osteoblast cells were harvested from 8-month old female Imprinting Control Region (ICR) mice. The effects of icariin stimulation on the proliferation, differentiation and maturation of osteoblasts were examined. The production of nitric oxide (NO) and caspase-3 were analyzed, along with the gene expressions of bone morphogenetic protein-2 (BMP-2), SMAD4, Cbfa1/Runx2, OPG, and RANKL. The viability of the osteoblasts reached its maximum at 10(-8)M icariin. At this concentration, icariin increased the proliferation and matrix mineralization of osteoblasts and promoted NO synthesis. With icariin treatment, the BMP-2, SMAD4, Cbfa1/Runx2, and OPG gene expressions were up-regulated; the RANKL gene expression was however down-regulated. Concurrent treatment involving the BMP antagonist (Noggin) or the NOS inhibitor (L-NAME) diminished the icariin-induced cell proliferation, ALP activity, NO production, as well as the BMP-2, SMAD4, Cbfa1/Runx2, OPG, RANKL gene expressions. In this study, we demonstrate that in vitro icariin is a bone anabolic agent that may exert its osteogenic effects through the induction of BMP-2 and NO synthesis, subsequently regulating Cbfa1/Runx2, OPG, and RANKL gene expressions. This effect may contribute to its action on the induction of osteoblasts proliferation and differentiation, resulting in bone formation.


Assuntos
Conservadores da Densidade Óssea/farmacologia , Epimedium/química , Flavonoides/farmacologia , Expressão Gênica/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Osteoblastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Conservadores da Densidade Óssea/uso terapêutico , Proteína Morfogenética Óssea 2/genética , Proteína Morfogenética Óssea 2/metabolismo , Caspases/biossíntese , Técnicas de Cultura de Células , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Subunidade alfa 1 de Fator de Ligação ao Core/genética , Subunidade alfa 1 de Fator de Ligação ao Core/metabolismo , Subunidades alfa de Fatores de Ligação ao Core/genética , Subunidades alfa de Fatores de Ligação ao Core/metabolismo , Feminino , Flavonoides/isolamento & purificação , Flavonoides/uso terapêutico , Genes , Peptídeos e Proteínas de Sinalização Intracelular/genética , Camundongos , Óxido Nítrico/biossíntese , Osteoblastos/metabolismo , Osteoporose/metabolismo , Osteoporose/prevenção & controle , Fitoterapia , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Ligante RANK/genética , Ligante RANK/metabolismo , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas Smad/genética , Proteínas Smad/metabolismo
13.
Artif Organs ; 30(3): 141-9, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16480388

RESUMO

In order to develop an adequate scaffold for skin tissue engineering, a bilayered gelatin-chondroitin 6 sulfate-hyaluronic acid membrane with a different pore size on either side was prepared. A rete ridges-like topographic microporous structure, which provided the paracrine crosstalk in the epithelial-mesenchymal interactions, was formed. Chondroitin-6-sulfate and hyaluronic acid were incorporated within the gelatin membrane to mimic skin composition and create an appropriate microenvironment for cell proliferation, differentiation, and migration. In the study, the lower layer of the membrane (pore size: 150 microm) was seeded with dermal fibroblasts and acted as the feeder layer for keratinocyte inoculation. Meanwhile, the upper layer (pore size: 20-50 microm) was seeded with keratinocytes for epidermalization. The dermal fibroblasts were dynamically seeded in a self-designed spinner flask for more even cell distribution. The keratinocytes were cultured in submerged conditions for 5 days and then in an air-liquid interface condition for further differentiation. After being cultured for 21 days, the upper layer, seeded with keratinocytes, developed into an epidermis-like structure while the lower part, which was seeded with dermal fibroblasts developed into a dermis-like structure. A histological examination and immunostain were used to prove that keratinocytes maintain their phenotype and stratified epidermis layers were formed within 21 days. In brief, the bilayered skin substitute with biological dermal analog and epidermal structure was successfully fabricated. From this study, we can suggest that the culture model is suitable for autologous skin equivalent preparation.


Assuntos
Adjuvantes Imunológicos/farmacologia , Sulfatos de Condroitina/farmacologia , Gelatina/farmacologia , Ácido Hialurônico/farmacologia , Pele Artificial , Engenharia Tecidual/métodos , Adulto , Movimento Celular , Proliferação de Células , Células Cultivadas , Técnicas de Cultura , Derme/ultraestrutura , Epiderme/ultraestrutura , Fibroblastos/citologia , Humanos , Queratinócitos/citologia , Microscopia Eletrônica de Varredura
14.
Am J Chin Med ; 32(5): 737-53, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15633809

RESUMO

We investigated the effects of Gu-Sui-Bu using in vitro bone cell cultures. Primary rabbit and mouse marrow cells were cultured with or without five different concentrations of Gu-Sui-Bu extract. Osteoclast numbers were assessed using tartrate-resistant acid phosphatase (TRAP) positive cell counts and for function, osteoclast resorption pits on bovine bone slices were performed. Alkaline phosphatase (AP) positive cell counts and mineralized nodule formation were examined to assess osteoblast function with Gu-Sui-Bu. TRAP+ osteoclast numbers increased, as did the number and size of resorption pits with 0.001 mg/ml of extract. Low doses of extract did not alter AP+ colony number or mineralized nodule formation, but both were inhibited by doses of 0.1 mg/ml or higher. The highest dose of extract (10 mg/ml) inhibited proliferation of all cell types. At 0.01 and 0.001 mg/ml doses, RANKL increased over time; however, osteoprotegerin levels only increased at doses > or = 0.1 mg/ml. Resorption pit formation was decreased without alteration in mature multinucleated (TRAP+) cell counts only at the highest dose of the putative active ingredient of Gu-Sui-Bu. In summary, lower concentrations of Gu-Sui-Bu extract had positive effects on osteoclast proliferation, survival and resorptive activity that may be mediated through enhanced prostaglandin secretion. However, high doses of extract proved detrimental to osteoclast and osteoblast survival. No effect of low doses of Gu-Sui-Bu extract was seen in osteoblast cultures. High doses of the putative active ingredient of Gu-Sui-Bu showed mild inhibition of mouse osteoclast function.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Osteoclastos/efeitos dos fármacos , Animais , Osso e Ossos/citologia , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Células Cultivadas , Citocinas/efeitos dos fármacos , Citocinas/metabolismo , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/química , Ensaio de Imunoadsorção Enzimática , Técnicas Imunoenzimáticas , Camundongos , Osteoclastos/metabolismo , Coelhos
15.
Biomaterials ; 24(13): 2413-22, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12699679

RESUMO

To accelerate the healing of bone defects or for healing to take place, it is often necessary to fill them with suitable substance. Various artificial materials defects have been developed. Among these, calcium phosphates and bioactive glass have been proven to be biocompatibile and bioactive materials that can chemically bond with bone, and have been successfully used clinically for repair of bone defects and augmentation of osseous tissue. However, those bioceramics have only the property of osteoconduction without any osteoinduction. Many ligands have been physicochemically absorbed onto substrates to enhance cell-substrate interactions. Although widely developed, they are still limited to use in long-term implantation because of their half-life period. Thus, some interfacial modification will be required for enhancing the efficacy of the delivery system. These models involve the immobilization of biologically active ligands of natural and synthetic origin onto various substrates to produce an interface with stronger chemical bond between ligand and substrate. The advantage of covalently immobilizing a ligand is that a chemical bond is present to prevent ligand or medicine from desorption. In our study, a two-step chemical immobilization was performed to surface-modified calcium hydrogenphosphate powders. The first was to modify the surface of calcium hydrogen-phosphate (CHP) with a coupling agent of hexanmethylene diisocyanate (HMDI). CHP surface modified by HMDI is abbreviated as MCHP. The linkage between CHP and HMDI will be characterized by FTIR. The second step was to immobilize chemically Gusuibu onto MCHP. Moreover, the sorption and desorption of Gusuibu was evaluated and quantitatively analyzed by spectrophotometer and HPLC. Bioceramic CHP was surface-modified by a two-step chemical immobilization. First, the surface of calcium hydrogen-phosphate (CHP) was successfully modified with coupling agent of hexanmethylene diisocyanate (HMDI). The first step was also activated the surface of CHP to induce primary amine terminator. The reaction of this functional group with Gusuibu was the second step. We confirmed simultaneously that Gusuibu could be immobilized chemically onto the surface of MCHP. Although some immobilized Gusuibu was also released rapidly at the first 12h, the degree of the released Gusuibu was lower than both by Gusuibu-adsorbing MCHP and Gusuibu-adsorbing CHP.


Assuntos
Substitutos Ósseos/química , Fosfatos de Cálcio/química , Materiais Revestidos Biocompatíveis/química , Implantes de Medicamento/química , Medicamentos de Ervas Chinesas/química , Fitoterapia/métodos , Polypodiaceae/química , Adsorção , Substitutos Ósseos/síntese química , Fosfatos de Cálcio/síntese química , Materiais Revestidos Biocompatíveis/síntese química , Materiais Revestidos Biocompatíveis/uso terapêutico , Implantes de Medicamento/administração & dosagem , Implantes de Medicamento/síntese química , Medicamentos de Ervas Chinesas/uso terapêutico , Teste de Materiais , Propriedades de Superfície
16.
Biomaterials ; 24(5): 873-82, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12485805

RESUMO

In our previous study, we have validated the efficacy and the safety of Gu-Sui-Bu [Drynaria fortunei (Kunze) J. Sm.] by the bone cells culture. However, a satisfactory delivery system for Gu-Sui-Bu must be developed before it can be used in clinical medicine. In this study, we try to use modified calcium hydrogenphosphate (MCHP) bioceramic as a carrier to transport Gu-Sui-Bu into the bone cell culture system. Toward this goal, we evaluated the effect of a Gu-Sui-Bu-immobilized modified calcium hydrogenphosphate (GI-MCHP) on the bone cells activities. THE CHINESE MEDICINE: Gu-Sui-Bu [Drynaria fortunei (kunze) J. Sm] was extracted and then immobilized on the surface of MCHP. The rat osteoblasts-osteoclasts co-culture system was used as the experimental model. After the cells grew to 80% confluence, different sizes of GI-MCHP particles were tested. The mitochondria activity of the bone cells after exposure was determined by colorimetric assay. Biochemical markers such as lactate dehydrogenase (LDH), alkaline phosphatase (ALP), acid phosphatase (ACP) and prostaglandin E(2) titer were analyzed to evaluate the bone cells activities. Histomorphometric study of osteoclasts activities and the phenotype expression of osteoblasts were also evaluated. There is no detectable titer of LDH secretion into the medium and no significant change in the intracellular ALP content. The ALP titer in the culture medium did increase significantly at 3 days' culture, while there is a significant decrease in the intracellular ACP content and significant increase in the ACP titer in the medium. The concentrations of PGE(2) in tested medium are always significantly higher than that of control medium during the 7 days' culture. At the end of 7 days' culture, the PGE(2) concentrations in the tested medium were still 4.74 times that of the control medium. After GI-MCHP treatment on bone cells, the size of the osteoclasts seems decreased and their cell integrity seems lost, while the osteoblasts phenotype expression was relatively preserved. From this study, we demonstrated that Gu-Sui-Bu [Drynaria fortunei (Kunze) J. Sm.] immobilized MCHP has well preserved the potential beneficial effects of Gu-Sui-Bu on the bone cells culture.


Assuntos
Fosfatos de Cálcio/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Gleiquênias , Medicina Tradicional Chinesa , Osteoblastos/citologia , Osteoclastos/citologia , Extratos Vegetais/farmacologia , Fosfatase Alcalina/análise , Animais , Sequência de Bases , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Colorimetria , Citoplasma/enzimologia , Primers do DNA , Dinoprostona/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Cinética , L-Lactato Desidrogenase/análise , Osteoblastos/efeitos dos fármacos , Osteoblastos/fisiologia , Osteocalcina/genética , Osteoclastos/efeitos dos fármacos , Osteoclastos/fisiologia , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Propriedades de Superfície , Taiwan , Fatores de Tempo
17.
Am J Chin Med ; 30(2-3): 271-85, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12230016

RESUMO

In this experiment, we investigate the biochemical effects of traditional Chinese medicines via an in vitro bone cell culture. Ten different Chinese medicines were used in this study. The rat osteoblast-osteoclast co-culture system was used as the experimental model. After the cells grew to 80% confluence, various tested materials were added. The mitochondria activity of the bone cells after exposure to various preparations of Chinese medicines was determined by colorimetric assay. Biochemical markers such as protein content, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), and acid phosphatase (ACP) titer were analyzed to evaluate the bone cell activity. When cultured with various Chinese medicines for 24 hours, only four of these ten Chinese medicines had potential beneficial effects on the bone cell culture; and only Drynaria fortunei (Kunze) J. Sm. had a universal beneficial effect on bone cell metabolism. The major beneficial effect of Drynaria fortunei (Kunze) J. Sm. on bone cells is probably mediated by the induction of apoptosis of the osteoclast cell population. Continued study of alterations in gene expression of bone cells caused by Chinese medicines will improve our understanding of bone cell responses to various pharmacological interventions.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Osteoblastos/efeitos dos fármacos , Fitoterapia , Polypodiaceae , Fosfatase Ácida/efeitos dos fármacos , Fosfatase Alcalina/efeitos dos fármacos , Animais , Linhagem Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Colorimetria , Relação Dose-Resposta a Droga , Imuno-Histoquímica , L-Lactato Desidrogenase/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Osteoblastos/enzimologia , Ratos
18.
Biomaterials ; 23(19): 4029-38, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12162336

RESUMO

316L-SS is one of the important materials both in orthopaedics and dentistry for bone screw/plate, intra-medullary rod, fixation wire, HIP joint, and knee joint. However, the biocompatibility and bone-bonding ability troubled researches for years. In the study, a simple chemical method was tried so as to establish and induce a bioactive HA layer on the surface of 316L stainless steel. When the metallic substrates treated with 10 M NaOH aqueous solution and subsequently heated at 600 degrees C, a thin sodium chromium oxide layer was formed on the surfaces as the linking layer for HA and 316L-SS. After 316L-SS treated with alkali solution, it would soak into a simulated body fluid with higher concentration of calcium and phosphorous ions to increase the possibility of nucleation of HA. However, the iron oxide and iron chromium oxides were formed on the surface when calcium and phosphorous ions increased. This resulted in loosening the HA layer. When the alkali-treated 316L-SS was soaked into SBF at a temperature of 80 degrees C, it could form a dense and uniform bone-like hydroxyapatite layer on the surface. In the research, the mechanism of the formation of sodium chromium oxide and HA would also be described by the analysis of X-ray diffractometer, scanning electron microscope, energy-dispersion spectrophotometer, and Fourier transformation infrared.


Assuntos
Materiais Biocompatíveis , Cálcio/química , Durapatita/química , Fósforo/química , Álcalis/farmacologia , Sangue/metabolismo , Compostos de Cromo/química , Compostos Férricos/química , Humanos , Íons , Teste de Materiais , Microscopia Eletrônica de Varredura , Modelos Químicos , Espectrofotometria , Espectroscopia de Infravermelho com Transformada de Fourier , Aço Inoxidável , Temperatura , Fatores de Tempo , Difração de Raios X
19.
Biomaterials ; 23(16): 3377-85, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12099280

RESUMO

In the traditional Chinese medicine, Gu-Sui-Bu [Drynaria fortunei (kunze) J. Sm] has been reported as a good enhancer for bone healing. In this experiment, we investigate the biochemical effects of this traditional Chinese medicine on the bone cells culture. Different concentrations of crude extract of Gu-Sui-Bu were added to rat bone cells culture. The mitochondria activity of the bone cells after exposure was determined by colorimetric assay. Biochemical markers such as alkaline phosphatase (ALP), acid phosphatase (ACP) titer, prostaglandin E2 (PGE2) titer and the expression of both osteopontin and osteonectin mRNA were evaluated. The effect on the osteoclasts differentiation was evaluated by tartrate-resistant acid phosphatase (TRAP) stain. The most effective concentration of Gu-Sui-Bu on bone cells was 1 mg/ml. The addition of 1 mg/ml Gu-Sui-Bu to bone cells culture for 7 days can statistically increase the intracellular ALP amount; while the ACP and PGE2 amount in culture medium were significantly increased. In Northern blot analysis, the expression of both osteopontin and osteonectin mRNA were down-regulated after adding Gu-Sui-Bu into bone cells culture. The formation of multi-nucleated osteoclasts was more active than that of the control group, but no giant osteoclasts formation was observed. In this study, we demonstrated that Gu-Sui-Bu has potential effects on the bone cells culture. One of the major effects of Gu-Sui-Bu on the bone cells is probably mediated by its effect on the osteclasts activities. Continued and advanced study on the alterations in gene expression of bone cells by Chinese medicines will provide a basis for understanding the observed bone cell responses to various pharmacological interventions.


Assuntos
Medicina Tradicional Chinesa , Osteoblastos/citologia , Extratos Vegetais/uso terapêutico , Fosfatase Ácida/metabolismo , Fosfatase Alcalina/metabolismo , Animais , Células Cultivadas , Dinoprostona/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/fisiologia , Osteoblastos/efeitos dos fármacos , Osteoblastos/fisiologia , Osteonectina/genética , Osteopontina , Fitoterapia , Polypodiaceae , RNA Mensageiro/genética , Ratos , Sialoglicoproteínas/genética , Transcrição Gênica/efeitos dos fármacos
20.
Bioelectromagnetics ; 23(4): 256-63, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-11948604

RESUMO

Low intensity ultrasound stimulation has been used as a strategy to promote fracture healing. This study investigated the mechanism of ultrasound stimulation in enhancing fracture healing. Forty-five adult New Zealand White rabbits were divided into control, microwave treated, and ultrasound stimulation groups. After anesthesia, transverse osteotomy was created at midportion of the fibula bone. Intravital staining followed by fluorescence microscopic examination of new bone formation in the osteotomy site and biomechanical tests on torsional stiffness of the osteotomy site were performed. The difference between each examination was evaluated and analyzed. After ultrasound stimulation, new bone formation in the osteotomy site of the stimulated limb was 23.1-35.8% faster than that of the sham treated limb; the torsional stiffness of the stimulated limb was 44.4-80.0% higher than that of the sham treated limb. In the group of microwave hyperthermia treatment, the new bone formation was higher than that of the sham treated limb, but the difference was not statistically significant. The difference in torsional stiffness between the microwave hyperthermia treated limbs and the sham treated limb was not quite statistically significant. We demonstrated that low intensity ultrasound stimulation could increase the new bone formation and torsional stiffness. These effects probably are not mediated via hyperthermia.


Assuntos
Consolidação da Fratura/efeitos da radiação , Hipertermia Induzida , Micro-Ondas , Terapia por Ultrassom , Animais , Fenômenos Biomecânicos , Desenvolvimento Ósseo/efeitos da radiação , Calibragem , Microscopia de Fluorescência , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA